A Novel Hypothesis: Regulatory B Lymphocytes Shape Outcome from Experimental Stroke (original) (raw)

• Chamorro A, Urra X, Planas AM. Infection after acute ischemic stroke: a minifestation of brain-induced immunodepression. Stroke. 2007;38:1097–103.
  Article PubMed Google Scholar
• Dirnagl U, Klehmet J, Braun JS, et al. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke. 2007;38:770–3.
  Article PubMed Google Scholar
• Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Neurosci Rev. 2005;6:775–86.
  Article CAS Google Scholar
• Akiyoshi K, Dziennis S, Palmateer J, et al. Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia. Transl Stroke Res. 2011;2:404–10.
  Article PubMed CAS Google Scholar
• Akiyoshi K, Ren X, Dziennis S, et al. Regulatory B-cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci. 2011;31:8556–63.
  Article PubMed Google Scholar
• Dziennis S, Kozaburo A, Subramanian S, Offner H, Hurn PD. Role of dihydrotestosterone in post-stroke peripheral immunosuppression after cerebral ischemia. Brain Behav Immun. 2011;25:685–95.
  Article PubMed CAS Google Scholar
• Dziennis S, Mader S, Akiyoshi K, et al. Therapy with recombinant T cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice. Metab Brain Dis. 2011;26:123–33.
  Article PubMed CAS Google Scholar
• Hurn PD, Subramanian S, Parker SM, et al. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab. 2007;27:1798–805.
  Article PubMed CAS Google Scholar
• Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab. 2006;26:654–65.
  Article PubMed CAS Google Scholar
• Offner H, Subramanian S, Parker SM, et al. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol. 2006;176:6523–31.
  PubMed CAS Google Scholar
• Offner H, Vandenbark AA, Hurn PD. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience. 2009;158:1098–111.
  Article PubMed CAS Google Scholar
• Ren X, Akiyoshi K, Grafe MR, et al. Myelin specific cells infiltrate MCAO lesions and exacerbate stroke severity. Metab Brain Dis. 2012;27:7–15.
  Article PubMed CAS Google Scholar
• Ren X, Akiyoshi K, Vandenbark AA, Hurn PD, Offner H. CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke. Metab Brain Dis. 2011;26:87–90.
  Article PubMed Google Scholar
• Ren X, Akiyoshi K, Vandenbark AA, Hurn PD, Offner H. Programmed death-1 pathway limits CNS inflammation and neurologic deficits in murine experimental stroke. Stroke. 2011;42:2578–83.
  Article PubMed Google Scholar
• Subramanian S, Zhang B, Kosaka Y, et al. Recombinant T cell receptor ligand treats experimental stroke. Stroke. 2009. doi:10.1161/STROKEAHA.108.543991.
• Zhang B, Subramanian S, Dziennis S, et al. Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke. J Immunol. 2010;184:4087–94.
  Article PubMed CAS Google Scholar
• Marsh BJ, Williams-Karnesky RL, Stenzel-Pore MP. Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience. 2008;158:1007–20.
  Article PubMed Google Scholar
• Gelderblom M, Leypoldt F, Steinbach K. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke. 2009;40:1849–57.
  Article PubMed Google Scholar
• Becker KJ. Anti-leukocyte antibodies: LeukArrest (Hu23F26) and Enlimomab (R6.5) in acute stroke. Curr Med Res Opin. 2002;19:18–22.
  Article Google Scholar
• Krams M, Lees KR, Hacke W. Acute stroke therapy by inhibition of neutrophils (ASTIN): an adaptive dose–response study of UK-279.276 in acute ischemic stroke. Stroke. 2003;34:2543–8.
  Article PubMed CAS Google Scholar
• Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol. 2001;2:816–22.
  Article PubMed CAS Google Scholar
• Dinesh RK, Hahn BH, Singh RP. PD-1, gender, and autoimmunity. Autoimmun Rev. 2010;9:583–7.
  Article PubMed Google Scholar
• Magnus T, Schreiner B, Korn T, et al. Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J Neurosci. 2005;25:2537–46.
  Article PubMed CAS Google Scholar
• Mason D, Powrie F. Control of immune pathology by regulatory T cells. Curr Opin Immunol. 1998;10:649–55.
  Article PubMed CAS Google Scholar
• Roncarolo MG, Levings MK. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol. 2000;12:676–83.
  Article PubMed CAS Google Scholar
• Shevach EM. Regulatory T cells in autoimmunity. Ann Rev Immunol. 2000;18:423–49.
  Article CAS Google Scholar
• Liesz A, Suri-Payer E, Veltkamp C, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med. 2009;15:192–9.
  Article PubMed CAS Google Scholar
• Kim JM, Rasmussen FP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol. 2007;8:191–7.
  Article PubMed CAS Google Scholar
• Grilli M, Barbieri I, Basudev H, et al. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur J Neurosci. 2000;12:2265–72.
  Article PubMed CAS Google Scholar
• Spera PA, Ellison JA, Feuerstein GZ, Barone FC. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett. 1998;251:189–92.
  Article PubMed CAS Google Scholar
• Dietrich WD, Busto R, Bethea JR. Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats. Exp Neurol. 1999;158:444–50.
  Article PubMed CAS Google Scholar
• Ooboshi H, Ibayashi S, Shichita T, et al. Postischemic gene transfer of intrleukin-10 protects against both focal and global brain ischemia. Circulation. 2005;111:913–9.
  Article PubMed CAS Google Scholar
• Frenkel D, Huang Z, Maron R, Koldzic DN, Moskowitz MA, Weiner HL. Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J Neurol Sci. 2005;233:125–32.
  Article PubMed CAS Google Scholar
• de Bilbao F, Arsenijevic D, Moll T, et al. In vivo over-expression of interleukin-10 increases resistance to focal brain ischemia in mice. J Neurochem. 2009;110:12–22.
  Article PubMed Google Scholar
• Vila N, Castillo J, Davalos A, Esteve A, Planas AM, Chamorro A. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke. 2003;34:671–5.
  Article PubMed CAS Google Scholar
• Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992;11:3887–95.
  PubMed CAS Google Scholar
• Keir ME, Francisco LM, Sharpe AH. PD-1 and its ligands in T-cell immunity. Curr Opin Immunol. 2007;19:309–14.
  Article PubMed CAS Google Scholar
• Nishimura H, Minato N, Nakano T, Honjo T. Immunological studies on PD-1-deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol. 1998;10:1563–72.
  Article PubMed CAS Google Scholar
• Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol. 2007;8:239–45.
  Article PubMed CAS Google Scholar
• Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol. 2006;27:195–201.
  Article PubMed CAS Google Scholar
• Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev. 2010;236:219–42.
  Article PubMed CAS Google Scholar
• Polanczyk MJ, Hopke C, Vandenbark AA, Offner H. Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). Int Immunol. 2007;19:337–43.
  Article PubMed CAS Google Scholar
• Wang C, Dehghani B, Li Y, et al. Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through up-regulation of programmed death 1. J Immunol. 2008;182:3294–303.
  Article Google Scholar
• Wang C, Dehghani B, Li Y, Kaler LJ, Vandenbark AA, Offner H. Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1. Immunology. 2009;126:329–35.
  Article PubMed CAS Google Scholar
• Schreiner B, Bailey SL, Shin T, Chen L, Miller SD. PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T cell responses in EAE. Eur J Immunol. 2008;38:2706–17.
  Article PubMed CAS Google Scholar
• Kuipers H, Muskens F, Willart M, et al. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Eur J Neuroimmunol. 2006;36:2472–82.
  Article CAS Google Scholar
• Phares TW, Ramakrishna C, Parra GI, et al. Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity. J Immunol. 2009;182:5430–8.
  Article PubMed CAS Google Scholar
• Kroner A, Schwab N, Ip CW, et al. PD-1 regulates neural damage in oligodendroglia-induced inflammation. PLoS One. 2009;4:e4405.
  Article PubMed Google Scholar